Rockville, MD 20850
Room TE 406/408/410
The NCI RNA Biology Initiative aims to facilitate the rapid exchange of information and expertise on the structure, function, biological roles, and therapeutic uses of RNA. Our goal is to foster synergistic interactions amongst NIH investigators and between NIH investigators and the larger scientific community. We anticipate that new insights into RNA biology and the development of innovative RNA-based tools and therapies will both define novel targets and accelerate the implementation of therapeutic interventions in cancer.
This one-day workshop will bring together leaders from industry, academia, and government with expertise in therapeutic oligonucleotides, delivery, small molecules, and preclinical development of novel RNA-based and RNA-targeted therapies.
- Amanda Hargrove, Ph.D., Professor of Chemistry, Duke University
- Chuong Hoang, M.D., FACS., Investigator, Thoracic Surgery Branch, CCR, NCI, NIH
- Eckhard Jankowsky, Ph.D., Vice President of RNA Science, Moderna Therapeutics
- Andrea Kasinski, Ph.D., William and Patty Miller Professor of Biological Sciences, Purdue University
- Alexis Komor, Ph.D., Assistant Professor, University of California, San Diego
- Jennifer Petter, Ph.D., Founder and Chief Innovation Officer, Arrakis Therapeutics
- Erik Sontheimer, Ph.D., Pillar Chair in Biomedical Research and Professor at the University of Massachusetts Chan Medical School